A detailed history of Allworth Financial LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Allworth Financial LP holds 10,650 shares of LLY stock, worth $8.14 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
10,650
Previous 13,448 20.81%
Holding current value
$8.14 Million
Previous $12.2 Million 22.51%
% of portfolio
0.06%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$772.14 - $960.02 $2.16 Million - $2.69 Million
-2,798 Reduced 20.81%
10,650 $9.44 Million
Q2 2024

Jul 23, 2024

BUY
$724.87 - $909.04 $4.4 Million - $5.52 Million
6,067 Added 82.2%
13,448 $12.2 Million
Q1 2024

Apr 25, 2024

BUY
$592.2 - $792.28 $1.1 Million - $1.47 Million
1,860 Added 33.69%
7,381 $5.74 Million
Q4 2023

Jan 24, 2024

BUY
$525.19 - $619.13 $122,369 - $144,257
233 Added 4.41%
5,521 $3.22 Million
Q3 2023

Oct 31, 2023

BUY
$434.7 - $599.3 $292,118 - $402,729
672 Added 14.56%
5,288 $2.84 Million
Q2 2023

Jul 18, 2023

BUY
$350.74 - $468.98 $246,219 - $329,223
702 Added 17.94%
4,616 $2.16 Million
Q1 2023

Apr 18, 2023

SELL
$310.63 - $364.82 $364,679 - $428,298
-1,174 Reduced 23.07%
3,914 $1.34 Million
Q4 2022

Jan 13, 2023

BUY
$321.55 - $374.67 $875,580 - $1.02 Million
2,723 Added 115.14%
5,088 $0
Q3 2022

Oct 18, 2022

BUY
$296.48 - $337.87 $51,884 - $59,127
175 Added 7.99%
2,365 $765,000
Q2 2022

Jul 13, 2022

BUY
$278.73 - $327.27 $145,497 - $170,834
522 Added 31.29%
2,190 $710,000
Q1 2022

Apr 22, 2022

BUY
$234.69 - $291.66 $48,580 - $60,373
207 Added 14.17%
1,668 $478,000
Q4 2021

Jan 21, 2022

BUY
$224.85 - $279.04 $15,739 - $19,532
70 Added 5.03%
1,461 $403,000
Q3 2021

Nov 02, 2021

BUY
$221.6 - $272.71 $157,557 - $193,896
711 Added 104.56%
1,391 $321,000
Q2 2021

Aug 02, 2021

SELL
$180.55 - $233.54 $123,676 - $159,974
-685 Reduced 50.18%
680 $156,000
Q1 2021

Apr 29, 2021

SELL
$164.32 - $212.72 $22,840 - $29,568
-139 Reduced 9.24%
1,365 $255,000
Q4 2020

Jan 26, 2021

BUY
$130.46 - $172.63 $43,051 - $56,967
330 Added 28.11%
1,504 $254,000
Q3 2020

Nov 03, 2020

SELL
$146.22 - $169.13 $36,408 - $42,113
-249 Reduced 17.5%
1,174 $174,000
Q1 2020

Apr 17, 2020

SELL
$119.05 - $147.35 $4,762 - $5,894
-40 Reduced 2.73%
1,423 $197,000
Q4 2019

Jan 16, 2020

BUY
$106.92 - $132.43 $17,214 - $21,321
161 Added 12.37%
1,463 $192,000
Q3 2019

Oct 09, 2019

BUY
$106.79 - $116.16 $8,009 - $8,712
75 Added 6.11%
1,302 $146,000
Q2 2019

Jul 25, 2019

BUY
$110.79 - $129.32 $28,916 - $33,752
261 Added 27.02%
1,227 $136,000
Q1 2019

May 07, 2019

BUY
$111.31 - $131.02 $333 - $393
3 Added 0.31%
966 $125,000
Q4 2018

Feb 11, 2019

BUY
$105.9 - $118.64 $82,178 - $92,064
776 Added 414.97%
963 $111,000
Q3 2018

Oct 30, 2018

BUY
$85.86 - $107.31 $1,287 - $1,609
15 Added 8.72%
187 $20,000
Q2 2018

Aug 08, 2018

SELL
$75.7 - $86.88 $5,601 - $6,429
-74 Reduced 30.08%
172 $15,000
Q1 2018

May 02, 2018

SELL
$74.21 - $87.6 $148 - $175
-2 Reduced 0.81%
246 $19,000
Q4 2017

Feb 22, 2018

SELL
$81.94 - $87.89 $6,882 - $7,382
-84 Reduced 25.3%
248 $21,000
Q3 2017

Oct 12, 2017

BUY
$77.07 - $85.54 $6,319 - $7,014
82 Added 32.8%
332 $28,000
Q2 2017

Aug 07, 2017

BUY
N/A
250
250 $21,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $727B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.